Exone end to end binder jetting service

Researchers 3D Print Cancerous Tumors Which Are Nearly Perfect for Clinical Studies

INTAMSYS industrial 3d printing

Share this Article

There has been a tremendous amount of research being done on the 3D printing of living human cells to form bones, organs, and various other tissue. Such technology is certain to change the way the medical community cancer-featviews regenerative medicine. There is another angle to this technology though, one in which 3D printing could end up being nearly as important to cancer research as it is to regenerative medicine.

Researchers, led by Wei Sun, a professor in the department of mechanical engineering at Drexel University, in Philadelphia, as well as Singhua University, in China, have come up with a method of 3D printing cancer cells.  They have done so, in such a way, that 90 percent of these cells survive and are able to be used in testing.

Currently billions of dollars a year are being spent on clinical trials, testing various drugs for any sign that they could help in the fight against cancer. There is a problem though. These tests use tiny, 2D, one layer thick structures of tumor cells, which allow researchers to test the various affects a drug can have on such a tumor.  However, these 2D sheets are not ideal, since actual tumors are grown with not two, but three dimensions.

cancer-1

Wei Sun

A 3D conglomerate of cancer cells should completely mimic that of an actual tumor found in a patient. This is where Wei Sun’s research has come into play. Sun was able to mix cervical cancer cells, with gelatin, and fibrous proteins, place them into a 3D printer,and layer by layer print out the sructure of a tumor. The cell structures were printed in a shape 10mm in length and width, and 2mm in height. After printing, he left the structures alone to grow for 8 days. As time passed they slowly formed into spherical balls of cells.

“With further understanding of these 3D models, we can use them to study the development, invasion, metastasis and treatment of cancer using specific cancer cells from patients. We can also use these models to test the efficacy and safety of new cancer treatment therapies and new cancer drugs,” said Sun.

The research being done here could potentially lead to more reliable testing of drugs, quicker FDA approval, and further understanding of how cancer cells replicate, as well as survive.  The ability for researchers to have at their disposal a tomorrow of any shape or size, could one day lead to some pretty amazing discoveries, or even cures for the terrible disease.  Discuss the latest on 3D printing of cancer cells, at 3dPrintboard.

(Header Image Source: : Zhao et al. Biofabrication)
(Results of study can be found at: iopscience.iop.org)

Share this Article


Recent News

3D Printing Webinar and Event Roundup: September 26, 2021

3D Printing News Briefs, September 25, 2021: Partnerships, Software, & More



Categories

3D Design

3D Printed Art

3D Printed Food

3D Printed Guns


You May Also Like

3D Systems Finalizes Sale of On-Demand Business, Will Operate as Quickparts

Pioneering additive manufacturing solutions provider 3D Systems finalized the $82 million deal for the sale of its on-demand 3D printing and custom manufacturing business. The rebranded company will operate as...

3D Printing Webinar and Event Roundup: September 19, 2021

We’ve got another busy week of webinars and events to tell you about! Topics in this week’s roundup run the gamut from 3D digital textures and FDM 3D printing potential...

3D Printing News Briefs, September 18, 2021: Business, Materials, & More

We’re filling up the front of today’s 3D Printing News Briefs with plenty of business, as one company celebrates an anniversary and two others welcome new executives to their ranks....

3D Printing Service Hubs Appoints New CEO, Alex Cappy

Changes are taking place at Hubs since it was acquired by manufacturing service provider Protolabs (Nasdaq: PRLB). Not only has the subsidiary removed the “3D” from its name, but it...


Shop

View our broad assortment of in house and third party products.